These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 38476236)

  • 1. Integrative analysis identifies oxidative stress biomarkers in non-alcoholic fatty liver disease via machine learning and weighted gene co-expression network analysis.
    Wang H; Cheng W; Hu P; Ling T; Hu C; Chen Y; Zheng Y; Wang J; Zhao T; You Q
    Front Immunol; 2024; 15():1335112. PubMed ID: 38476236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of potential feature genes in non-alcoholic fatty liver disease using bioinformatics analysis and machine learning strategies.
    Zhang Z; Wang S; Zhu Z; Nie B
    Comput Biol Med; 2023 May; 157():106724. PubMed ID: 36898287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of immune related genes and possible regulatory mechanisms in different stages of non-alcoholic fatty liver disease.
    He R; Guan C; Zhao X; Yu L; Cui Y
    Front Immunol; 2024; 15():1364442. PubMed ID: 38524129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of biomarkers for the diagnosis of chronic kidney disease (CKD) with non-alcoholic fatty liver disease (NAFLD) by bioinformatics analysis and machine learning.
    Cao Y; Du Y; Jia W; Ding J; Yuan J; Zhang H; Zhang X; Tao K; Yang Z
    Front Endocrinol (Lausanne); 2023; 14():1125829. PubMed ID: 36923221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated bioinformatics and machine-learning screening for immune-related genes in diagnosing non-alcoholic fatty liver disease with ischemic stroke and RRS1 pan-cancer analysis.
    Bao H; Li J; Zhang B; Huang J; Su D; Liu L
    Front Immunol; 2023; 14():1113634. PubMed ID: 37090698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unveiling the mitophagy puzzle in non-alcoholic fatty liver disease (NAFLD): Six hub genes for early diagnosis and immune modulatory roles.
    Luo Z; Yan S; Chao Y; Shen M
    Heliyon; 2024 Apr; 10(7):e28935. PubMed ID: 38601640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of neutrophil extracellular trap-related biomarkers in non-alcoholic fatty liver disease through machine learning and single-cell analysis.
    Fang Z; Liu C; Yu X; Yang K; Yu T; Ji Y; Liu C
    Sci Rep; 2024 Sep; 14(1):21085. PubMed ID: 39256536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioinformatics analysis reveals novel core genes associated with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
    Feng G; Li XP; Niu CY; Liu ML; Yan QQ; Fan LP; Li Y; Zhang KL; Gao J; Qian MR; He N; Mi M
    Gene; 2020 Jun; 742():144549. PubMed ID: 32184169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of common signature genes and pathways underlying the pathogenesis association between nonalcoholic fatty liver disease and heart failure.
    Li G; Lu Z; Chen Z
    Front Immunol; 2024; 15():1424308. PubMed ID: 39351239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of machine learning based integration to identify the crosslink between inflammation and immune response in non-alcoholic fatty liver disease through bioinformatic analysis.
    Yu R; Huang Y; Hu X; Chen J
    Heliyon; 2024 Jul; 10(14):e32783. PubMed ID: 39108890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microarray-based Detection of Critical Overexpressed Genes in the Progression of Hepatic Fibrosis in Non-alcoholic Fatty Liver Disease: A Protein-protein Interaction Network Analysis.
    Mahmoudi A; Butler AE; De Vincentis A; Jamialahmadi T; Sahebkar A
    Curr Med Chem; 2024; 31(23):3631-3652. PubMed ID: 37194229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and validation of INHBE and P4HA1 as hub genes in non-alcoholic fatty liver disease.
    Cao J; Zhong Q; Huang Y; Zhu M; Wang Z; Xiong Z
    Biochem Biophys Res Commun; 2023 Dec; 686():149180. PubMed ID: 37922570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrative network-based analysis on multiple Gene Expression Omnibus datasets identifies novel immune molecular markers implicated in non-alcoholic steatohepatitis.
    Zhang JJ; Shen Y; Chen XY; Jiang ML; Yuan FH; Xie SL; Zhang J; Xu F
    Front Endocrinol (Lausanne); 2023; 14():1115890. PubMed ID: 37008925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential diagnostic markers shared between non-alcoholic fatty liver disease and atherosclerosis determined by machine learning and bioinformatic analysis.
    Wang L; He W; Wang X; Wang J; Wei X; Wu D; Wu Y
    Front Med (Lausanne); 2024; 11():1322102. PubMed ID: 38606153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Machine learning and weighted gene co-expression network analysis identify a three-gene signature to diagnose rheumatoid arthritis.
    Wu YK; Liu CD; Liu C; Wu J; Xie ZG
    Front Immunol; 2024; 15():1387311. PubMed ID: 38711508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploration and validation of key genes associated with early lymph node metastasis in thyroid carcinoma using weighted gene co-expression network analysis and machine learning.
    Liu Y; Yin Z; Wang Y; Chen H
    Front Endocrinol (Lausanne); 2023; 14():1247709. PubMed ID: 38144565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of diagnostic gene signatures and molecular mechanisms for non-alcoholic fatty liver disease and Alzheimer's disease through machine learning algorithms.
    Jiang L; Wang Q; Jiang Y; Peng D; Zong K; Li S; Xie W; Zhang C; Li K; Wu Z; Huang Z
    Clin Chim Acta; 2024 Apr; 557():117892. PubMed ID: 38537674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal tubular gen e biomarkers identification based on immune infiltrates in focal segmental glomerulosclerosis.
    Bai J; Pu X; Zhang Y; Dai E
    Ren Fail; 2022 Dec; 44(1):966-986. PubMed ID: 35713363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated Bioinformatics Analysis Identifies Robust Biomarkers and Its Correlation With Immune Microenvironment in Nonalcoholic Fatty Liver Disease.
    Zhang F; Zhang Z; Li Y; Sun Y; Zhou X; Chen X; Sun S
    Front Genet; 2022; 13():942153. PubMed ID: 35910194
    [No Abstract]   [Full Text] [Related]  

  • 20. Identification and validation of potential diagnostic signature and immune cell infiltration for NAFLD based on cuproptosis-related genes by bioinformatics analysis and machine learning.
    Ouyang G; Wu Z; Liu Z; Pan G; Wang Y; Liu J; Guo J; Liu T; Huang G; Zeng Y; Wei Z; He S; Yuan G
    Front Immunol; 2023; 14():1251750. PubMed ID: 37822923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.